 |
 |
> > I apologise for the difficulties related to the attachment file. I also > apologise for the use of technical terms (for example medicinal > compound names), as some of you kindly pointed out. However, I must use > them for a very simple reason: commercial brand names > in Europe are different from those in the US, let alone Asia. These > names are the only universal ones at my disposal. > > It is likely that I will travel to the US during 1998. The purpose of my > trip is to compare American and European treatment strategies. > Hopefully I will find some kind of correlation between pharmacological > treatments and their outcomes. If there are any particular > people in the US that I should get in touch with, please feel free to > make suggestions. > > Samppa Suoniemi > [log in to unmask] > Fax: +358-2-3383 451 > > Here are the questions: > > > 1. Sex: 1. Male > _____________________________________ > > 2. Nationality __Italian_______________________________ > > 3. Age 3. above 65 ___ > > 4. How long ago were You diagnosed with PD? > 1. 0-5 years ago ___ > > > 5. What medications are You taking at the moment? > > 4. dopamine agonist - Mirapex > > 6. In general, are You satisfied with the effectiveness of Your > medication? somewhat - other than side -effects > > 7. How often are You troubled by the following symptoms (on a scale from > 1 to 5, 1=all the time 5=never): > tremor _4 > rigidity 3___ > slowness of movement 1___ > postural instability 2___ > dyskinesia 5 > hallucinations 5___ > dementia 5 > depression 2 > dystonia 5 > sexual problems > 8. How disabling are the following symptoms (on a scale from 1 to 5, > 1=extremely disabling 5=no disability): > tremor 5 > rigidity 4 ___ > slowness of movement 2 ___ > postural instability 2___ > > 9. Have You ever been hospitalized due to PD symptoms? Which symptom(s)? > > NO